688302 海创药业
已收盘 06-02 15:00:00
资讯
新帖
简况
大额解禁在即，商业化预期难言乐观，海创药业的“四年之约”道阻且艰
新浪证券 · 06-01 18:37
大额解禁在即，商业化预期难言乐观，海创药业的“四年之约”道阻且艰
【机构调研记录】华富基金调研道森股份、海创药业
证券之星 · 06-01 08:54
【机构调研记录】华富基金调研道森股份、海创药业
【机构调研记录】中信建投基金调研水发燃气、海创药业等5只个股（附名单）
证券之星 · 06-01 08:30
【机构调研记录】中信建投基金调研水发燃气、海创药业等5只个股（附名单）
【机构调研记录】圆信永丰基金调研海创药业、鹿山新材
证券之星 · 06-01 08:30
【机构调研记录】圆信永丰基金调研海创药业、鹿山新材
海创药业：5月26日进行路演，东方资管、重阳战略投资等多家机构参与
证券之星 · 05-31 19:16
海创药业：5月26日进行路演，东方资管、重阳战略投资等多家机构参与
海创药业(688302.SH)：截止第一季度末公司账户有约15亿元货币资金
格隆汇资讯 · 05-31 16:30
海创药业(688302.SH)：截止第一季度末公司账户有约15亿元货币资金
海创药业(688302.SH)：研发人员数量占公司总人数比例提升至72.84%
格隆汇资讯 · 05-31 16:29
海创药业(688302.SH)：研发人员数量占公司总人数比例提升至72.84%
海创药业(688302.SH)：成都“研发生产基地建设项目”目前主体已封顶
格隆汇资讯 · 05-31 16:28
海创药业(688302.SH)：成都“研发生产基地建设项目”目前主体已封顶
海创药业(688302.SH)：目前PROTAC蛋白靶向降解技术平台已有多个在研品种
格隆汇资讯 · 05-31 16:26
海创药业(688302.SH)：目前PROTAC蛋白靶向降解技术平台已有多个在研品种
海创药业(688302.SH)：HC-1119中枢神经系统毒性风险较恩扎卢胺减少50%
格隆汇资讯 · 05-31 16:25
海创药业(688302.SH)：HC-1119中枢神经系统毒性风险较恩扎卢胺减少50%
海创药业(688302.SH)：争取HC-1119能早日获批上市并成功实现商业化
格隆汇资讯 · 05-31 16:24
海创药业(688302.SH)：争取HC-1119能早日获批上市并成功实现商业化
海创药业（688302）5月30日主力资金净买入9.41万元
证券之星 · 05-31
海创药业（688302）5月30日主力资金净买入9.41万元
西南证券：给予海创药业买入评级
证券之星 · 05-25
西南证券：给予海创药业买入评级
西南证券给予海创药业买入评级 德恩鲁胺NDA审评中 在研管线加速推进
每日经济新闻 · 05-25
西南证券给予海创药业买入评级 德恩鲁胺NDA审评中 在研管线加速推进
海创药业（688302）5月24日主力资金净卖出898.57万元
证券之星 · 05-25
海创药业（688302）5月24日主力资金净卖出898.57万元
海创药业：董事易宇辞任
每经网 · 05-19
海创药业：董事易宇辞任
5月19日海创药业-U涨5.10%，鹏华医药科技股票A基金重仓该股
证券之星 · 05-19
5月19日海创药业-U涨5.10%，鹏华医药科技股票A基金重仓该股
海创药业（688302）5月17日主力资金净卖出279.40万元
证券之星 · 05-18
海创药业（688302）5月17日主力资金净卖出279.40万元
全球最权威创新药大会之一将召开，多家A股公司将亮相
华尔街见闻 · 05-17
全球最权威创新药大会之一将召开，多家A股公司将亮相
公司概况
公司名称：
海创药业股份有限公司
所属行业：
医药制造业
上市日期：
2022-04-12
主营业务：
海创药业股份有限公司是一家基于氘代技术和PROTAC靶向蛋白降解等技术平台，以开发具有重大临床需求的Best-in-class（同类最佳）、First-in-class（国际首创）药物为目标的国际化创新药企业。公司的主要产品为肿瘤、代谢性疾病药品。公司在肿瘤和代谢性疾病领域重点布局，重点搭建了氘代药物研发平台、PROTAC靶向蛋白降解技术平台、靶向药物发现与验证平台与先导化合物优化筛选平台，形成了较强的研发优势和丰富的技术储备。
发行价格：
42.92
{"stockData":{"symbol":"688302","market":"SH","secType":"STK","nameCN":"海创药业","latestPrice":64.18,"timestamp":1685689200000,"preClose":65.89,"halted":0,"volume":534078,"delay":0,"floatShares":23769600,"shares":99015600,"eps":-2.9287,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.71,"latestTime":"06-02 15:00:00","open":64.9,"high":66.3,"low":63.56,"amount":34372900,"amplitude":0.0416,"askPrice":64.28,"askSize":50,"bidPrice":64.18,"bidSize":12,"shortable":0,"etf":0,"ttmEps":-2.9287,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1685928600000},"adr":0,"adjPreClose":65.89,"symbolType":"stock_kcb","highLimit":72.48,"lowLimit":59.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":99015598,"pbRate":4.16,"roa":"--","roe":"--","epsLYR":-3.32,"committee":-0.318182,"marketValue":6355000000,"floatMarketCap":1526000000,"peRate":-21.91416,"changeRate":-0.026,"turnoverRate":0.0225,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2023-06-05。","afterMarket":{"amount":0,"volume":0,"close":64.18,"buyVolume":0,"sellVolume":0,"time":1685691237938,"indexStatus":"已收盘 06-02 15:30:00","preClose":65.89}},"requestUrl":"/m/hq/s/688302/wiki","defaultTab":"wiki","newsList":[{"id":"2340206610","title":"大额解禁在即，商业化预期难言乐观，海创药业的“四年之约”道阻且艰","url":"https://stock-news.laohu8.com/highlight/detail?id=2340206610","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2340206610?lang=zh_CN&edition=full","pubTime":"2023-06-01 18:37","pubTimestamp":1685615868,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023060118375782582ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023060118375782582ba5&s=b","is_publish_highlight":false},{"id":"2340124234","title":"【机构调研记录】华富基金调研道森股份、海创药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2340124234","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2340124234?lang=zh_CN&edition=full","pubTime":"2023-06-01 08:54","pubTimestamp":1685580857,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023060108542083e5464a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023060108542083e5464a&s=b","is_publish_highlight":false},{"id":"2340958244","title":"【机构调研记录】中信建投基金调研水发燃气、海创药业等5只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2340958244","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2340958244?lang=zh_CN&edition=full","pubTime":"2023-06-01 08:30","pubTimestamp":1685579439,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023060100007395.shtml","is_publish_highlight":false},{"id":"2340244993","title":"【机构调研记录】圆信永丰基金调研海创药业、鹿山新材","url":"https://stock-news.laohu8.com/highlight/detail?id=2340244993","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2340244993?lang=zh_CN&edition=full","pubTime":"2023-06-01 08:30","pubTimestamp":1685579420,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023060100007384.shtml","is_publish_highlight":false},{"id":"2339326404","title":"海创药业：5月26日进行路演，东方资管、重阳战略投资等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2339326404","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2339326404?lang=zh_CN&edition=full","pubTime":"2023-05-31 19:16","pubTimestamp":1685531774,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023053100028197.shtml","is_publish_highlight":false},{"id":"2339636272","title":"海创药业(688302.SH)：截止第一季度末公司账户有约15亿元货币资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2339636272","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2339636272?lang=zh_CN&edition=full","pubTime":"2023-05-31 16:30","pubTimestamp":1685521818,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023053116302383e3e851&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023053116302383e3e851&s=b","is_publish_highlight":false},{"id":"2339263935","title":"海创药业(688302.SH)：研发人员数量占公司总人数比例提升至72.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2339263935","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2339263935?lang=zh_CN&edition=full","pubTime":"2023-05-31 16:29","pubTimestamp":1685521763,"startTime":"0","endTime":"0","summary":"格隆汇5月31日丨有投资者向海创药业(688302.SH)提问：请公司介绍研发投入及研发人员情况？海创药业回复：2022年，公司研发投入金额25,136.73万元，与上年同期基本持平。截至2022年12月底，公司研发人员数量达118人，较上年同期增长24.21%。研发人员中95.76%为本科及以上学历，硕士博士占比43.22%，研发人员数量占公司总人数比例提升至72.84%。公司重视对各类优秀人才的吸引和发展，建立优秀人才队伍是公司将创新药物从研发推向商业化的不竭动力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305311630468255024d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305311630468255024d&s=b","is_publish_highlight":false},{"id":"2339026360","title":"海创药业(688302.SH)：成都“研发生产基地建设项目”目前主体已封顶","url":"https://stock-news.laohu8.com/highlight/detail?id=2339026360","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2339026360?lang=zh_CN&edition=full","pubTime":"2023-05-31 16:28","pubTimestamp":1685521718,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023053116300382550203&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023053116300382550203&s=b","is_publish_highlight":false},{"id":"2339263622","title":"海创药业(688302.SH)：目前PROTAC蛋白靶向降解技术平台已有多个在研品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2339263622","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2339263622?lang=zh_CN&edition=full","pubTime":"2023-05-31 16:26","pubTimestamp":1685521613,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023053116265683e3e6e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023053116265683e3e6e6&s=b","is_publish_highlight":false},{"id":"2339268487","title":"海创药业(688302.SH)：HC-1119中枢神经系统毒性风险较恩扎卢胺减少50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2339268487","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2339268487?lang=zh_CN&edition=full","pubTime":"2023-05-31 16:25","pubTimestamp":1685521521,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305311625278254ff80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305311625278254ff80&s=b","is_publish_highlight":false},{"id":"2339684822","title":"海创药业(688302.SH)：争取HC-1119能早日获批上市并成功实现商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2339684822","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2339684822?lang=zh_CN&edition=full","pubTime":"2023-05-31 16:24","pubTimestamp":1685521460,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305311624478254ff1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305311624478254ff1f&s=b","is_publish_highlight":false},{"id":"2339313082","title":"海创药业（688302）5月30日主力资金净买入9.41万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2339313082","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2339313082?lang=zh_CN&edition=full","pubTime":"2023-05-31 08:44","pubTimestamp":1685493847,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023053100006928.shtml","is_publish_highlight":false},{"id":"2338431132","title":"西南证券：给予海创药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2338431132","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2338431132?lang=zh_CN&edition=full","pubTime":"2023-05-25 11:20","pubTimestamp":1684984835,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052500015892.shtml","is_publish_highlight":false},{"id":"2338724139","title":"西南证券给予海创药业买入评级 德恩鲁胺NDA审评中 在研管线加速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2338724139","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2338724139?lang=zh_CN&edition=full","pubTime":"2023-05-25 10:02","pubTimestamp":1684980153,"startTime":"0","endTime":"0","summary":"西南证券05月25日发布研报称，给予海创药业（688302.SH，最新价：69.31元）买入评级。评级理由主要包括：1）德恩鲁胺NDA获受理，有望成为国内获批转移性去势抵抗性前列腺癌；2）URAT1抑制剂和ARPROTAC产品研发加速推进；3）PROTAC等技术平台奠定持续自主创新能力，多款临床阶段产品值得期待。风险提示：研发或审评审批进展不及预期风险，市场竞争加剧风险，医药行业政策风险等。AI点评：海创药业近一个月获得2份券商研报关注，增持2家。文章来源：每日经济新闻原标题：西南证券给予海创药业买入评级，德恩鲁胺NDA审评中，在研管线加速推进","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052510090483d6cc3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052510090483d6cc3d&s=b","is_publish_highlight":false},{"id":"2338418084","title":"海创药业（688302）5月24日主力资金净卖出898.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2338418084","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2338418084?lang=zh_CN&edition=full","pubTime":"2023-05-25 07:52","pubTimestamp":1684972346,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023052500007895.shtml","is_publish_highlight":false},{"id":"2336511514","title":"海创药业：董事易宇辞任","url":"https://stock-news.laohu8.com/highlight/detail?id=2336511514","media":"每经网","top":-1,"share":"https://www.laohu8.com/m/news/2336511514?lang=zh_CN&edition=full","pubTime":"2023-05-19 19:28","pubTimestamp":1684495738,"startTime":"0","endTime":"0","summary":"海创药业 5月19日晚间发布公告称，易宇女士因个人工作安排原因申请辞去公司第一届董事会董事职务，易宇女士辞职后将不再担任公司任何职务。海创药业的总经理、董事长均是YUANWEI CHEN(陈元伟)，男，60岁，学历背景为博士。截至发稿，海创药业市值为73亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305191939378235e0d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305191939378235e0d0&s=b","is_publish_highlight":false},{"id":"2336591279","title":"5月19日海创药业-U涨5.10%，鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2336591279","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2336591279?lang=zh_CN&edition=full","pubTime":"2023-05-19 15:34","pubTimestamp":1684481646,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023051900017820.shtml","is_publish_highlight":false},{"id":"2336325033","title":"海创药业（688302）5月17日主力资金净卖出279.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2336325033","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2336325033?lang=zh_CN&edition=full","pubTime":"2023-05-18 08:24","pubTimestamp":1684369467,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023051800008388.shtml","is_publish_highlight":false},{"id":"2336325627","title":"全球最权威创新药大会之一将召开，多家A股公司将亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=2336325627","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2336325627?lang=zh_CN&edition=full","pubTime":"2023-05-17 16:04","pubTimestamp":1684310685,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051716031384719b65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051716031384719b65&s=b","is_publish_highlight":false}],"profile":{"ret":0,"listingDate":"2022-04-12","address":"四川省成都市武侯区高新区科园南路5号蓉药大厦1栋4层附2、3号","stockEarnings":[{"period":"1week","weight":-0.0767},{"period":"1month","weight":-0.1439},{"period":"3month","weight":0.1197},{"period":"6month","weight":0.4933},{"period":"1year","weight":0.744},{"period":"ytd","weight":0.5918}],"companyName":"海创药业股份有限公司","boardCode":"AI0027","perCapita":"8035股","boardName":"医药制造业","registeredCapital":"9901万元","compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.028},{"period":"3month","weight":-0.0295},{"period":"6month","weight":0.0234},{"period":"1year","weight":0.0108},{"period":"ytd","weight":0.0456}],"survey":" 海创药业股份有限公司是一家基于氘代技术和PROTAC靶向蛋白降解等技术平台，以开发具有重大临床需求的Best-in-class（同类最佳）、First-in-class（国际首创）药物为目标的国际化创新药企业。公司的主要产品为肿瘤、代谢性疾病药品。公司在肿瘤和代谢性疾病领域重点布局，重点搭建了氘代药物研发平台、PROTAC靶向蛋白降解技术平台、靶向药物发现与验证平台与先导化合物优化筛选平台，形成了较强的研发优势和丰富的技术储备。","serverTime":1685776619215,"listedPrice":42.92,"stockholders":"2958人(较上一季度减少34.19%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.13.0","shortVersion":"4.13.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海创药业(688302)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海创药业(688302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海创药业,688302,海创药业股票,海创药业股票老虎,海创药业股票老虎国际,海创药业行情,海创药业股票行情,海创药业股价,海创药业股市,海创药业股票价格,海创药业股票交易,海创药业股票购买,海创药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海创药业(688302)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海创药业(688302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}